| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Oct―11 |
Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19 |
Elvira Maličev, Klemen Žiberna, Katerina Jazbec, Ana Kolenc, Polonca Mali, Urška Rahne Potokar, Primož Rožman |
| 2 |
[GO] |
2023―Apr―03 |
Too Early to Abandon Convalescent Plasma for Supportive Treatment of COVID-19 |
Rainer Seitz, Lutz Gürtler, Ute Vahlensieck, Anneliese Hilger, Wolfgang Schramm |
| 3 |
[GO] |
2022―Apr―25 |
Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis |
Zhangcheng Fei, Zhongsheng Chen, Xi Du, Haijun Cao, Changqing Li |
| 4 |
[GO] |
2022―Mar―23 |
Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review |
Philip Kiely, Veronica C. Hoad, Clive R. Seed, Iain B. Gosbell |
| 5 |
[GO] |
2022―Feb―08 |
The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis |
Cindy Chiem, Khader Alghamdi, Thao Nguyen, Joon Hee Han, Hongzhao Huo, Denise Jackson |
| 6 |
[GO] |
2021―Aug―20 |
COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers |
Pierre-Louis Conan, Cécile Ficko, Marine Chueca, Carole Rolland, Olivier Javaudin, Christine Bigaillon, et al. (+8) Guillaume-André Durand, Isabelle Leparc-Goffart, Catherine Verret, Marc Aletti, Fabien Dutasta, Hélène Savini, Jean-Luc Bosson, Christophe Martinaud |
| 7 |
[GO] |
2021―May―25 |
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections |
Enrico Richter, Doaa Al Arashi, Bianca Schulte, Christian Bode, Benjamin Marx, Souhaib Aldabbagh, et al. (+9) Celina Schlüter, Beate Mareike Kümmerer, Johannes Oldenburg, Markus B. Funk, Christian Putensen, Ricarda Maria Schmithausen, Gunther Hartmann, Anna Eis-Hübinger, Hendrik Streeck |
| 8 |
[GO] |
2021―Apr―21 |
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies |
Sixten Körper, Bernd Jahrsdörfer, Victor M. Corman, Jan Pilch, Patrick Wuchter, Rainer Blasczyk, et al. (+15) Rebecca Müller, Torsten Tonn, Tamam Bakchoul, Richard Schäfer, David Juhl, Tatjana Schwarz, Nina Gödecke, Thomas Burkhardt, Michael Schmidt, Thomas Appl, Hermann Eichler, Harald Klüter, Christian Drosten, Erhard Seifried, Hubert Schrezenmeier |
| 9 |
[GO] |
2021―Apr―07 |
Relationship of SARS-CoV-2 Pandemic with Blood Groups |
Didar Yanardag Acik, Mehmet Bankir |
| 10 |
[GO] |
2021―Mar―29 |
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry |
Daniel Katz, Patrick Maher, Chloe Getrajdman, Joshua Hamburger, Shan Zhao, Jonathan Madek, et al. (+3) Himani Bhatt, Matthew Levin, Klaus Görlinger |
| 11 |
[GO] |
2021―Mar―29 |
Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism |
Lisa Weidner, Julia Kalser, Thomas R. Kreil, Christof Jungbauer, Wolfgang R. Mayr |
|
